Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?

Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Madrigal Pharmaceuticals Stock (NASDAQ: MDGL) stock price, news, charts, stock research, profile.

Open	$278.88
Close	$290.74
Volume / Avg.	356.13K / 455.81K
Day Range	277.48 - 292.07
52 Wk Range	119.76 - 299.98
Market Cap	$6.20B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	30.17%
Days to Cover	5.62

Recent News

What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment. Further trials needed to confirm efficacy and safety.

Vandana Singh

DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Madrigal Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Madrigal Pharmaceuticals (MDGL) stock?

You can purchase shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) through any online brokerage.

View our list of the best stock brokerages

Who are Madrigal Pharmaceuticals (MDGL) competitors?

Other companies in Madrigal Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and Exact Sciences (NASDAQ:EXAS).

What is the target price for Madrigal Pharmaceuticals (MDGL) stock?

There is no analysis for Madrigal Pharmaceuticals.

What is the forecast for Madrigal Pharmaceuticals (MDGL) stock?

Madrigal Pharmaceuticals has a consensus price target of $295.24.

Current stock price for Madrigal Pharmaceuticals (MDGL)?

The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $290.74 last updated Today at July 8, 2024 at 4:00 PM EDT.

Does Madrigal Pharmaceuticals (MDGL) pay a dividend?

There are no upcoming dividends for Madrigal Pharmaceuticals.

When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?

Madrigal Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is Madrigal Pharmaceuticals (MDGL) going to split?

There is no upcoming split for Madrigal Pharmaceuticals.

What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?

Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals (MDGL) Forecast